TORRES ARTHUR A
Known title: DirectorCIK: 0001251737
TORRES ARTHUR A's purchase track record
TORRES ARTHUR A has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/5/2021 | CDNA | $29K | -14.4% | -45.2% | -12.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CDNA | ▼ Sell | Open Market | 6,484 | $129K | 5/15/2026 | View on chart |
| CDNA | ▼ Sell | Open Market | 4,086 | $86K | 5/14/2026 | View on chart |
| CDNA | ▲ Buy | Grant | 12,103 | $0 | 6/13/2025 | View on chart |
| CDNA | ▲ Buy | Grant | 10,570 | $0 | 6/14/2024 | View on chart |
| CDNA | ▲ Buy | Grant | 18,844 | $0 | 6/16/2023 | View on chart |
| CDNA | ▲ Buy | Grant | 4,863 | $0 | 6/16/2022 | View on chart |
| CDNA | ▲ Buy | Open Market | 600 | $29K | 11/5/2021 | View on chart |
| CDNA | ▲ Buy | Grant | 2,255 | $0 | 9/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
CareDx shows high growth and fair‑value boost after reimbursement news
Recent coverage noted CareDx’s strong revenue growth and improving fundamentals. Analyst updates cited new reimbursement information and target revisions, leading to a modest fair‑value increase. The company’s performance appears to be gaining attention among investors.
CareDx shows high growth and fair‑value boost after reimbursement news. Recent coverage noted CareDx’s strong revenue growth and improving fundamentals. Analyst updates cited new reimbursement information and target revisions, leading to a modest fair‑value increase. The company’s performance appears to be gaining attention among investors.